SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pharmaids Pharma - Quaterly Results

04 Aug 2023 Evaluate
A slight decline in the revenue of Rs. 0.00 millions was seen for the June 2023 quarter as against Rs. 0.00 millions during year-ago period.The Net Loss for the quarter ended June 2023 is Rs. -13.37 millions as compared to Net Loss of Rs. -1.43 millions of corresponding quarter ended June 2022 Operating profit Margin for the quarter ended June 2023 further decreased to -12.35% as compared to -0.55% of corresponding quarter ended June 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 39.39 0.00
Other Income 3.72 0.00 0.00 3.72 0.00 0.00 0.00 0.15 0.00
PBIDT -12.35 -0.55 2145.45 -12.35 -0.55 2145.45 -98.87 1.52 -6604.61
Interest 0.01 0.03 -66.67 0.01 0.03 -66.67 0.05 0.03 66.67
PBDT -12.36 -0.58 2031.03 -12.36 -0.58 2031.03 -98.92 1.49 -6738.93
Depreciation 0.08 0.00 0.00 0.08 0.00 0.00 0.17 0.09 88.89
PBT -12.44 -0.58 2044.83 -12.44 -0.58 2044.83 -99.09 1.40 -7177.86
TAX 0.93 0.85 9.41 0.93 0.85 9.41 -23.52 -0.05 46940.00
Deferred Tax 0.93 0.85 9.41 0.93 0.85 9.41 -23.52 -0.05 46940.00
PAT -13.37 -1.43 834.97 -13.37 -1.43 834.97 -75.57 1.45 -5311.72
Equity 214.86 103.11 108.38 214.86 103.11 108.38 214.44 102.69 108.82
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.86 0.00

Pharmaids Pharma Share Price

30.92 -0.49 (-1.56%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×